A Randomised, Double Blind, Placebo Controlled Efficacy and Safety Trial of Different Doses/Dose Regimens of FP187 Compared to Placebo in Moderate to Severe Plaque Psoriasis (Pivotal Registration Study)
Phase of Trial: Phase II
Latest Information Update: 10 Dec 2012
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- 22 Sep 2012 Status changed from active, no longer recruiting to completed as reported by EudraCT.
- 07 Feb 2012 Actual patient number (252) added as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.